Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

DIRECTOR DEALINGS: Proteome Sciences Non-Executive Buys Shares

Tue, 08th Jul 2014 17:00

LONDON (Alliance News) - Proteome Sciences PLC Tuesday said Non-Executive Director Roger McDowell bought 500,00 shares at a price of 37.474 pence per share, his only holding in the company.

The stock closed up 13.6% at 37.50 pence Tuesday.

By Anthony Tshibangu; anthonytshibangu@alliancenews.com;

Copyright 2014 Alliance News Limited. All Rights Reserved.

Related Shares

More News
16 May 2024 12:23

IN BRIEF: Proteome Sciences promises AGM return to growth in 2024

Proteome Sciences PLC - London-based protein-focused drug development services provider - Proteome tells annual general meeting on Thursday it is "con...

16 May 2024 10:41

AIM WINNERS & LOSERS: Proteome Sciences eyes return to growth in 2024

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Thursday.

26 Apr 2024 11:18

Proteome wins GBP500,000 deal to supply mass spectrometry services

(Alliance News) - Proteome Sciences PLC on Friday said it won a contract from an unnamed US biopharmaceutical company to use Proteome's mass spectrome...

26 Apr 2024 10:40

AIM WINNERS & LOSERS: Proteome Sciences rises on GBP500,000 contract

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Friday.

26 Apr 2024 09:45

Proteome Sciences secures contract win with US biopharmaceutical firm

(Sharecast News) - Contract proteomics service Proteome Sciences has secured a contract win from a US biopharmaceutical company using the company's ma...

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.